| Literature DB >> 22623956 |
Stéphanie Berzigotti1, Kamal Benlafya, Jérémy Sépulchre, Ana Amoroso, Bernard Joris.
Abstract
In Bacillus licheniformis 749/I, BlaP β-lactamase is induced by the presence of a β-lactam antibiotic outside the cell. The first step in the induction mechanism is the detection of the antibiotic by the membrane-bound penicillin receptor BlaR1 that is composed of two functional domains: a carboxy-terminal domain exposed outside the cell, which acts as a penicillin sensor, and an amino-terminal domain anchored to the cytoplasmic membrane, which works as a transducer-transmitter. The acylation of BlaR1 sensor domain by the antibiotic generates an intramolecular signal that leads to the activation of the L3 cytoplasmic loop of the transmitter by a single-point cleavage. The exact mechanism of L3 activation and the nature of the secondary cytoplasmic signal launched by the activated transmitter remain unknown. However, these two events seem to be linked to the presence of a HEXXH zinc binding motif of neutral zinc metallopeptidases. By different experimental approaches, we demonstrated that the L3 loop binds zinc ion, belongs to Gluzincin metallopeptidase superfamily and is activated by self-proteolysis.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22623956 PMCID: PMC3356374 DOI: 10.1371/journal.pone.0036400
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Membrane topology of the penicillin-sensory transducer, BlaR1.
This receptor contains two domains, an extracellular domain: BlaR-CTD and a transmembrane domain: BlaR-NTD. BlaR-CTD exhibits the three motifs of the penicillin binding protein family (S*402TYK, Y476GN, K539TG, where S402 is the active serine). BlaR-NTD includes four transmembrane segments (TM1, TM2, TM3, TM4) connected by three loops (L1, L2, L3). The cytoplasmic L3 loop contains the H212EXXH motif, characteristic to zinc-metalloproteases.
Figure 2Sequence alignment of the amino-terminal domain of the proteins B. licheniformis 749/I BlaR1 (BlBlaR-NTD) and S. aureus RN4220 BlaR1 (SaBlaR-NTD) and S. aureus MRSA252 MecR (SaMecR-NTD).
The conserved residues are highlighted in red and the loop and transmembrane segments are marked: the transmembrane segments (TM1 to 4) in orange; the extracellular loops B1 (M1-P8) and L2 (P53-S115) in green and the cytoplasmic loops L1 (K27-T35) and L3 (Y134-K322) in blue. The site of cleavage, situated between the R293 and R294 in S. aureus BlaR1, is indicated by an arrow.
Induction of BlaPβ-lactamase of the BlaR1 L3 loop mutants.
| Mutation | Plasmids | Induction factor | |
|
| pDML995 | 37.8±1.5 | |
|
| H212A/E213A/H216A | pDML1268 | 1.6±0.1 |
| E213A | pDML1269 | 1.2±0.1 | |
| H212A/H216A | pDML1270 | 1.2±0.1 | |
| H216A | pDML1271 | 1.27±0.01 | |
| E213D | pDML1279 | 1.07±0.02 | |
| E213Q | pDML1280 | 1.6±0.2 | |
|
| D221A | pDML1277 | 1.2±0.1 |
| E253A | pDML1273 | 1.2±0.3 | |
| D257A | pDML1274 | 1.9±0.1 | |
| E274A | pDML1275 | 33.9±0.9 | |
|
| Y 272A | pDML1278 | 1.1±0.1 |
|
| R304A/R305A | pDML3045 | 7.6±1.7 |
The induction factor corresponds to the ratio between the β-lactamase quantity/A600 for induced culture and the β-lactamase quantity/A600 for uninduced culture.
Bacterial strains and plasmids used in this study.
| Strain or plasmid | Relevant characteristic(s) | Source |
|
| β-lactamase inducible strain, wild-type | |
|
| Recipient cell for | ATCC 23857 |
|
| Host cell for heterologous expression of BlaR1 L3, F-, lamda-, | Invitrogen |
| pUCBM20 | Cloning plasmid, Apr | Boehringer |
| pCR-ScriptTMSK(+) | Cloning vector for PCR fragments, Apr | Stratagene |
| pLEX | Expression vector from inducible P-lambda promoter, Apr | Novagen |
| pDML995 | A derivative of the | A. Brans (unpublished) |
| pDML1251 | pUCBM20 derivative carrying the | This study |
| pDML1255 | pDML1251 derivative carrying BlaR1H212A/E213A/H216A mutation | This study |
| pDML1256 | pDML1251 derivative carrying BlaR1 E213A mutation | This study |
| pDML1257 | pDML1251 derivative carrying BlaR1 H212A/H216A mutation | This study |
| pDML1258 | pDML1251 derivative carrying BlaR1 H216A mutation | This study |
| pDML1260 | pDML1251 derivative carrying BlaR1 E253A mutation | This study |
| pDML1261 | pDML1251 derivative carrying BlaR1 D257A mutation | This study |
| pDML1262 | pDML1251 derivative carrying BlaR1 E274A mutation | This study |
| pDML1264 | pDML1251 derivative carrying BlaR1 D221A mutation | This study |
| pDML1265 | pDML1251 derivative carrying BlaR1 Y272A mutation | This study |
| pDML1266 | pDML1251 derivative carrying BlaR1 E213D mutation | This study |
| pDML1267 | pDML1251 derivative carrying BlaR1 E213Q mutation | This study |
| pDML1268 | pDML995 derivative carrying BlaR1 H212A/E213A/H216A mutation | This study |
| pDML1269 | pDML995 derivative carrying BlaR1 E213A mutation | This study |
| pDML1270 | pDML995 derivative carrying BlaR1 H212A/H216A mutation | This study |
| pDML1271 | pDML995 derivative carrying BlaR1 H216A mutation | This study |
| pDML1273 | pDML995 derivative carrying BlaR1 E253A mutation | This study |
| pDML1274 | pDML995 derivative carrying BlaR1 D257Amutation | This study |
| pDML1275 | pDML995 derivative carrying BlaR1 E274A mutation | This study |
| pDML1277 | pDML995 derivative carrying BlaR1 D221A mutation | This study |
| pDML1278 | pDML995 derivative carrying BlaR1 Y272A mutation | This study |
| pDML1279 | pDML995 derivative carrying BlaR1 E213D mutation | This study |
| pDML1280 | pDML995 derivative carrying BlaR1 E213Q mutation | This study |
| pDML3045 | pDML995 derivative carrying BlaR1 R304A/R305A mutation | This study |
| pDML1283 | pCR-ScriptTMSK(+) derivative carrying BlaR1 L3 loop coding sequence | This study |
| pDML1284 | pDML1283 derivative carrying BlaR1 L3 E213A mutation | This study |
| pDML1285 | pDML1283 derivative carrying BlaR1 L3 H212A/H216A mutation | This study |
| pDML1286 | pDML1283 derivative carrying BlaR1 L3 D257A mutation | This study |
| pDML1287 | pDML1283 derivative carrying BlaR1 L3 D221A mutation | This study |
| pDML1293 | pDML1283 derivative carrying BlaR1 L3 E253A mutation | This study |
| pDML1288 | pLEX derivative allowing the expression of BlaR1 L3 loop | This study |
| pDML1289 | pLEX derivative allowing the expression of BlaR1 L3 carrying E213A mutation | This study |
| pDML1290 | pLEX derivative allowing the expression of BlaR1 L3 carrying H212A/H216A mutation | This study |
| pDML1291 | pLEX derivative allowing the expression of BlaR1 L3 carrying D257A mutation | This study |
| pDML1292 | pLEX derivative allowing the expression of BlaR1 L3 carrying D221A mutation | This study |
| pDML1294 | pLEX derivative allowing the expression of BlaR1 L3 carrying E253A mutation | This study |
Apr: ampicillin resistance.
Cmr: chloramphenicol resistance.
Figure 3Western blot analysis of membrane-bound BlaR1 produced by B. subtilis strains carrying plasmids harboring blaR1 mutants.
Membrane proteins from induced (+) or uninduced (-) cultures were separatedon on SDS-PAGE. Purified BlaR-CTD antibodies were used for the Western blotting. Pre-stained protein molecular weight markers were used (M). The pinpoints an intense and non-specific band (for details see Figure 6). BlaR1 and BlaR1* point out, respectively, the full size and the activated B. licheniformis BlaR1 receptor. Except for mutant E274A, all other mutants exhibit non-inducible β-lactamase phenotype. The E274A mutant has the same profile as the wild-type (to compare see Figure 6). For details see Tables 1 and 2 and Experimental procedures.
Figure 6Western blot analysis of membranes of B. subtilis transformed with pMK4 (negative control), pDML995 (wild type), pDML1269 (E213A mutant) or pDML3045 (R304A/R305A mutant).
Membrane proteins from induced (+) or uninduced (−) cultures were separatedon on SDS-PAGE. Purified BlaR-CTD antibodies were used for the Western blotting. Pre-stained protein molecular weight markers were used (M). The indicates an intense and non-specific band. BlaR1 and BlaR1* highlight, respectively, the full size and the activated B. licheniformis BlaR1 receptor.
Figure 4Coomassie Blue-stained SDS-PAGE of partially purified inclusion bodies of wild-type and L3 loop mutants (A) and Zinc blot analysis (B).
In A and B: 1: bovine carbonic anhydrase (AC) (∼30 kDa; 5 µg), was used as positive control and 2 to 6 are, respectively, wild type (WT), E213A, H212A/H216A, D257 A, D221 A and E253 A L3 loop mutants. For each gel 40 µg of inclusion bodies were loaded. The fluorographies were exposed at -70°C for 72 hours. M: molecular weight marker. The arrow indicates L3 loops.
Figure 5Induction of β-lactamase synthesis in presence (induced) or not (non-induced) of inducer (2.5 µg ml−1 cephalosporin C) for the B. subtilis strains transformed with pDML995 (wild-type divergeon; •) or pDML3045 (mutation R304A/R305A;○).
The level of the induction is expressed as an induction factor (IF, the ratio between the β-lactamase quantity/A600 for induced culture and the β-lactamase quantity/A600 for uninduced culture).
Oligonucleotides used in this study.
| Name | Nucleotide sequence | Utilities |
| L3up |
| L3 loop sequence |
| L3rp |
| amplification |
| E213Aup |
| Mutation |
| E213Arp |
| E213A |
| H212AH216Aup |
| Mutation |
| H212AH216Arp |
| H212A/H216A |
| H212AE213AH216Aup |
| Mutation |
| H212AE213AH216Arp |
| H212A/E213A/H212A |
| E253Aup |
| Mutation |
| E253Arp |
| E253A |
| D257Aup |
| Mutation |
| D257Arp |
| D257A |
| D221Aup |
| Mutation |
| D221Arp |
| D221A |
| Y272Aup |
| Mutation |
| Y272Arp |
| Y272A |
| E274Aup |
| Mutation |
| E274Arp |
| E274A |
| E213Qup |
| Mutation |
| E213Qrp |
| E213Q |
| E213Dup |
| Mutation |
| E213Drp |
| E213D |
| R304AR305Aup |
| Mutation |
| R304AR305Arp |
| R304A/R305A |
Modified codons are underlined and mutagenised bases are highlighted.